Seminoma secondary prevention: Difference between revisions

Jump to navigation Jump to search
Line 8: Line 8:
==Secondary Prevention==
==Secondary Prevention==


Effective measures for the secondary prevention of seminoma include:<ref>{{cite journal|doi=10.1016/j.radonc.2012.12.002 showArticle Info}}</ref>
Effective measures for the secondary prevention of seminoma include:<ref>{{cite journal|doi=10.1016/j.radonc.2012.12.002 showArticle Info}}</ref><ref name="pmid21819630">{{cite journal |vauthors=Boujelbene N, Cosinschi A, Boujelbene N, Khanfir K, Bhagwati S, Herrmann E, Mirimanoff RO, Ozsahin M, Zouhair A |title=Pure seminoma: a review and update |journal=Radiat Oncol |volume=6 |issue= |pages=90 |date=August 2011 |pmid=21819630 |pmc=3163197 |doi=10.1186/1748-717X-6-90 |url=}}</ref>
* Follow-up patients  
* Follow-up patients  
**Every 2–6 months for the first 3 years
**Every 2–6 months for the first 3 years

Revision as of 15:42, 6 May 2019

Seminoma Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Seminoma from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Staging

TNM
Stage Grouping

History and Symptoms

Physical Examination

Laboratory Findings

Chest X Ray

CT

MRI

Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Treatment - Stage I
Treatment - Stage II
Treatment - Stage III
Treatment - Recurrent

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Seminoma secondary prevention On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Seminoma secondary prevention

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Seminoma secondary prevention

CDC on Seminoma secondary prevention

Seminoma secondary prevention in the news

Blogs on Seminoma secondary prevention

Directions to Hospitals Treating Seminoma

Risk calculators and risk factors for Seminoma secondary prevention

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Sujit Routray, M.D. [2]

Overview

Secondary prevention strategies following seminoma include regular follow-ups for every 2–6 months for the first 3 years and every 6–12 months after 3 years. Tests are often part of follow-up care include blood tests to check serum tumor marker levels, chest x-rays, and CT scans of the abdomen and pelvis.

Secondary Prevention

Effective measures for the secondary prevention of seminoma include:[1][2]

  • Follow-up patients
    • Every 2–6 months for the first 3 years
    • Every 6–12 months after 3 years
  • Follow-up test include:
    • Blood tests to check serum tumor marker levels to see if they returned to normal after treatment
    • Chest x-rays to check if cancer has metastasized to the lungs
    • CT scans of the abdomen and pelvis to look for any residual disease or that has metastasized elsewhere

References

  1. . doi:10.1016/j.radonc.2012.12.002 showArticle Info Check |doi= value (help). Missing or empty |title= (help)
  2. Boujelbene N, Cosinschi A, Boujelbene N, Khanfir K, Bhagwati S, Herrmann E, Mirimanoff RO, Ozsahin M, Zouhair A (August 2011). "Pure seminoma: a review and update". Radiat Oncol. 6: 90. doi:10.1186/1748-717X-6-90. PMC 3163197. PMID 21819630.

Template:WH Template:WS